HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of ranolazine for rhythm control in an elderly patient with paroxysmal atrial fibrillation.

Abstract
We report the case of an elderly woman with coronary heart disease and paroxysmal atrial fibrillation. It could be hypothesized that the predisposing anatomic substrate for arrhythmogenesis in this patient derived from both age-related left atrial dilation and coexistent ischaemic heart disease. Unfortunately the usual antiarrhythmic therapy was unsafe or not feasible for this subject. Ranolazine 750 mg twice daily completely suppressed atrial fibrillation recurrences.
AuthorsE Santillo, M Migale, D Postacchini, L Fallavollita, L Marini, F Balestrini
JournalLa Clinica terapeutica (Clin Ter) Vol. 165 Issue 2 Pg. e166-9 ( 2014) ISSN: 1972-6007 [Electronic] Italy
PMID24770828 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Acetanilides
  • Piperazines
  • Ranolazine
Topics
  • Acetanilides (therapeutic use)
  • Aged
  • Atrial Fibrillation (drug therapy)
  • Female
  • Humans
  • Piperazines (therapeutic use)
  • Ranolazine
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: